Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Therapeutic Advances in Gastroenterology|October 6, 2022
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort studyJessica Howell, Amit Samani, Binish Mannan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 10, 2020
Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using 18F-Fluorothymidine PETRohini Sharma, Marianna Inglese, Suraiya Dubash, et al.
BMJ Open|November 20, 2025
Individualised dosimetry for holmium-166 RE in patients with unresectable hepatocellular carcinoma; a multi-centre, interventional, non-randomised, non-comparative, open label, phase II study: RHEPaiRMaria Qurashi, Maria Martinez, Caroline Ward, et al.
Liver Cancer|March 6, 2023
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver DiseaseHaonan Lu, Jacob George, Mohammed Eslam, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2019
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinomaJessica Howell, Stephen R Atkinson, David J Pinato, et al.
Physics in Medicine and Biology|May 11, 2012
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapyKaiyumars Contractor, Amarnath Challapalli, Giampaolo Tomasi, et al.
Frontiers in Pharmacology|March 20, 2023
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinomaCan G Leineweber, Miriam Rabehl, Anne Pietzner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 28, 2023
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UKVictoria Hamill, Will Gelson, Douglas MacDonald, et al.
Frontiers in Pharmacology|January 26, 2024
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinomaCan G Leineweber, Miriam Rabehl, Anne Pietzner, et al.
Liver Cancer|December 14, 2017
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational StudyClarence Yen, Rohini Sharma, Lorenza Rimassa, et al.
Pageof 17